GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dicot AB (XSAT:DICOT) » Definitions » 5-Year RORE %

Dicot AB (XSAT:DICOT) 5-Year RORE % : -43.04% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Dicot AB 5-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Dicot AB's 5-Year RORE % for the quarter that ended in Mar. 2024 was -43.04%.

The industry rank for Dicot AB's 5-Year RORE % or its related term are showing as below:

XSAT:DICOT's 5-Year RORE % is ranked worse than
85.54% of 906 companies
in the Drug Manufacturers industry
Industry Median: 3.125 vs XSAT:DICOT: -43.04

Dicot AB 5-Year RORE % Historical Data

The historical data trend for Dicot AB's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dicot AB 5-Year RORE % Chart

Dicot AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
5-Year RORE %
Get a 7-Day Free Trial - - - -17.70 -37.44

Dicot AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -28.58 -32.24 -40.83 -37.44 -43.04

Competitive Comparison of Dicot AB's 5-Year RORE %

For the Drug Manufacturers - Specialty & Generic subindustry, Dicot AB's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dicot AB's 5-Year RORE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dicot AB's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where Dicot AB's 5-Year RORE % falls into.



Dicot AB 5-Year RORE % Calculation

Dicot AB's 5-Year RORE % for the quarter that ended in Mar. 2024 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( -0.07--0.772 )/( -1.631-0 )
=0.702/-1.631
=-43.04 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2024 and 5-year before.


Dicot AB  (XSAT:DICOT) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Dicot AB 5-Year RORE % Related Terms

Thank you for viewing the detailed overview of Dicot AB's 5-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dicot AB (XSAT:DICOT) Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 30, Uppsala, SWE, SE 752 37
Dicot AB is engaged in developing drugs against sexual dysfunction in Sweden. Its important products are Libiguin which is used for the treatment of erectile dysfunction and premature ejaculation in men, as well as potentially also for the treatment of decreased lust.

Dicot AB (XSAT:DICOT) Headlines

No Headlines